| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with mercuric bromide co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of EVC2 mRNA" | 27188386 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with Phenylmercuric Acetate co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of EVC2 mRNA" | 27188386 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with mercuric bromide co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of EVC2 mRNA" | 27188386 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with Phenylmercuric Acetate co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of EVC2 mRNA" | 27188386 |
| D000082 | Acetaminophen | Acetaminophen results in increased expression of EVC2 mRNA | 29067470 |
| D000082 | Acetaminophen | Acetaminophen affects the expression of EVC2 mRNA | 17562736 |
| D016604 | Aflatoxin B1 | Aflatoxin B1 results in increased expression of EVC2 mRNA | 23630614 |
| D001564 | Benzo(a)pyrene | Benzo(a)pyrene results in decreased expression of EVC2 mRNA | 22316170 |
| D001564 | Benzo(a)pyrene | Benzo(a)pyrene results in increased mutagenesis of EVC2 gene | 25435355 |
| D001564 | Benzo(a)pyrene | Benzo(a)pyrene promotes the reaction [AHR protein binds to EVC2 promoter] | 19654925 |
| D004958 | Estradiol | Estradiol affects the expression of EVC2 mRNA | 22574217 |
| C006780 | bisphenol A | bisphenol A results in decreased expression of EVC2 mRNA | 25181051 |
| C018475 | butyraldehyde | butyraldehyde results in decreased expression of EVC2 mRNA | 26079696 |
| D002794 | Choline | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of EVC2 mRNA | 20938992 |
| D003471 | Cuprizone | Cuprizone results in decreased expression of EVC2 mRNA | 26577399 |
| D005492 | Folic Acid | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of EVC2 mRNA | 20938992 |
| C482199 | lipopolysaccharide, E coli O55-B5 | "lipopolysaccharide, E coli O55-B5 results in increased expression of EVC2 mRNA" | 24972896 |
| C042720 | mercuric bromide | "[NOG protein co-treated with mercuric bromide co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of EVC2 mRNA" | 27188386 |
| D008694 | Methamphetamine | Methamphetamine results in increased expression of EVC2 mRNA | 28341135 |
| D008715 | Methionine | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of EVC2 mRNA | 20938992 |
| D008741 | Methyl Methanesulfonate | Methyl Methanesulfonate results in increased expression of EVC2 mRNA | 23649840 |
| D018817 | N-Methyl-3,4-methylenedioxyamphetamine | "N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of EVC2 mRNA" | 20188158 |
| C523799 | MRK 003 | EVC2 results in increased susceptibility to MRK 003 | 19903844 |
| D037742 | Nanotubes, Carbon | "Nanotubes, Carbon results in decreased expression of EVC2 mRNA" | 25620056 |
| D010662 | Phenylmercuric Acetate | "[NOG protein co-treated with Phenylmercuric Acetate co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of EVC2 mRNA" | 27188386 |
| D010662 | Phenylmercuric Acetate | Phenylmercuric Acetate results in decreased expression of EVC2 mRNA | 26272509 |
| D013849 | Thimerosal | Thimerosal results in decreased expression of EVC2 mRNA | 27188386 |
| D014635 | Valproic Acid | Valproic Acid results in decreased expression of EVC2 mRNA | 28001369 |
| D014635 | Valproic Acid | Valproic Acid results in decreased expression of EVC2 mRNA | 21427059 |
| D014635 | Valproic Acid | Valproic Acid results in increased expression of EVC2 mRNA | 21427059 |